Loading cancer entity…
Loading cancer entity…
Clinical trials
24 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00874861 | HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas | completed | Early Phase 1 | 10 | Ian F. Pollack, M.D.OTHER | 1 | Dec 8, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Dec 8, 2015source: clinicaltrials